Andrew Fisher serves as Executive at Verona Pharma plc, where they oversee executive responsibilities. Since joining the company, Andrew Fisher has executed 7 insider transactions totaling $125.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 7, 2025 involved selling 931,984 shares valued at $0.
Andrew Fisher currently holds 931,984 shares of Verona Pharma plc (VRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Fisher has been a net seller of VRNA stock. They have purchased $0 and sold $125.9K worth of shares.
Andrew Fisher's most recent insider trade was on Oct 7, 2025, when they sold 931,984 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 7, 2025 | VRNA | $0 | Option Exercise | 931,984 | $N/A | Discretionary |
| Aug 1, 2025 | VRNA | $125.9K | Sale | 9,584 | $13.14 | Discretionary |
| Aug 1, 2025 | VRNA | $0 | Option Exercise | 20,888 | $N/A | Discretionary |
| Jul 8, 2025 | VRNA | $451.5K | Payment | 39,464 | $11.44 | Discretionary |
| Jul 7, 2025 | VRNA | $0 | Option Exercise | 86,064 | $N/A | Discretionary |